Q Global Advisors, LLC - PHOENIX BIOTECH ACQUISITION ownership

Quarter-by-quarter ownership
Q Global Advisors, LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2023$12
+20.0%
170,7850.0%0.01%
+14.3%
Q2 2023$10
+42.9%
170,7850.0%0.01%
+40.0%
Q1 2023$70.0%170,7850.0%0.01%
+66.7%
Q4 2022$7
-99.9%
170,7850.0%0.00%
-62.5%
Q3 2022$12,000
-29.4%
170,7850.0%0.01%
-38.5%
Q2 2022$17,000
-54.1%
170,7850.0%0.01%
-43.5%
Q1 2022$37,000
-11.9%
170,785
+70.8%
0.02%
+130.0%
Q4 2021$42,000100,0000.01%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q4 2023
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 163,538$1,639,0000.08%
Radcliffe Capital Management, L.P. 150,000$1,503,0000.04%
Telemetry Investments, L.L.C. 125,114$13,0000.02%
Q Global Advisors, LLC 170,785$17,0000.01%
Atalaya Capital Management LP 225,000$25,0000.00%
MMCAP International Inc. SPC 375,000$38,0000.00%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 677,408$88,0000.00%
Alpine Global Management, LLC 55,100$6,0000.00%
Sage Rock Capital Management LP 91,999$9,0000.00%
Bulldog Investors, LLP 51,757$5,0000.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders